Chemicon Sublicenses RNAi Technology from Promega

genomeweb
360dx

Chemicon Sublicenses RNAi Technology from Promega

Feb 17, 2004

NEW YORK, Feb. 17 (GenomeWeb News) - Chemicon International has sub-licensed an RNAi technology from Promega, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Genome of Medieval Relapsing Fever Pathogen Provides Insights Into Microbe's Evolution
GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech
OpGen Partners With NYS DOH, Merck Subsidiary for Antimicrobial Resistance Surveillance
Top Five Articles on GenomeWeb Last Week: Qiagen, Premaitha, Roche, and More
Interpace Receives Approval to Commercialize New Thyroid Test in New York, Pennsylvania
NeoGenomics to Participate in NCI-MATCH

The Scan

To Control the Spread

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

More to Do

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

This Week in PLOS

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

'Follow Me to Maryland'

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

Main menu